Side Effects

Hypoglycemia on GLP-1: Who Is at Risk and How to Stay Safe

If you're taking or considering a GLP-1 medication like semaglutide or tirzepatide, you've probably heard that these medications are relatively safe when it comes to low blood sugar. That's true for most people. But "most people" doesn't mean everyone, and understanding whether you might be at higher risk for hypoglycemia can make all the difference in your treatment experience.

Let's talk about who needs to be extra cautious, what puts you at risk, and how to protect yourself while getting the most from your GLP-1 therapy.

Understanding Why GLP-1s Are Generally Low Risk for Hypoglycemia

GLP-1 receptor agonists work with your body's natural systems in a smart way. They stimulate insulin release only when your blood sugar is elevated, and they suppress glucagon (a hormone that raises blood sugar) only when it's not needed. This glucose-dependent mechanism means that when your blood sugar is already normal or low, these medications essentially take a back seat.

That's why most people taking GLP-1s alone don't experience hypoglycemia. The medication doesn't push your blood sugar down regardless of where it starts—it helps normalize it.

But there are important exceptions to this general safety profile.

Who Is Actually at Risk for Hypoglycemia on GLP-1s

People Taking Other Diabetes Medications

This is the biggest risk factor. If you're combining a GLP-1 with medications that can independently cause low blood sugar, your risk increases significantly.

Sulfonylureas like glipizide, glyburide, and glimepiride are common culprits. These medications force your pancreas to release insulin regardless of your blood sugar level, which can combine with GLP-1 effects to drop your glucose too low.

Insulin is the other major concern. Many people with type 2 diabetes use both insulin and GLP-1s together, which can be very effective but requires careful dose adjustments, especially when starting GLP-1 therapy.

If you're on either of these medication types, your doctor should be proactively adjusting your doses when adding a GLP-1 to prevent hypoglycemia.

People with Type 1 Diabetes Using GLP-1s Off-Label

While GLP-1 medications aren't FDA-approved for type 1 diabetes, some endocrinologists prescribe them off-label to help with weight management and blood sugar control. Because people with type 1 diabetes are always on insulin, the hypoglycemia risk is inherently higher and requires very close monitoring.

People with Advanced Kidney Disease

Your kidneys play an important role in clearing medications from your body and regulating blood sugar. If you have moderate to severe chronic kidney disease, medications may stay in your system longer, and your body's ability to respond to low blood sugar may be impaired.

This doesn't mean you can't use GLP-1s—many are actually kidney-protective—but it does mean you need closer monitoring and possibly dose adjustments.

Older Adults with Multiple Health Conditions

Age alone doesn't put you at risk, but older adults are more likely to have multiple conditions and take multiple medications. They may also have a reduced ability to recognize hypoglycemia symptoms or may not respond as quickly to low blood sugar.

Additionally, older adults may eat less consistently or have changes in kidney or liver function that affect medication processing.

People Who Drink Alcohol Regularly

Alcohol interferes with your liver's ability to release stored glucose when your blood sugar drops. If you drink regularly, especially without food, you face a higher risk of hypoglycemia on any diabetes medication, including combinations involving GLP-1s.

Those with Unpredictable Eating Patterns

While GLP-1s reduce appetite—which is often desired—skipping meals entirely or eating very inconsistently can increase hypoglycemia risk if you're on other diabetes medications. The GLP-1 itself typically won't cause lows from missed meals, but the combination with other drugs might.

Gender Considerations in Hypoglycemia Risk

Research suggests that women may experience hypoglycemia slightly more frequently than men when taking diabetes medications, though the reasons aren't completely understood. Hormonal fluctuations throughout the menstrual cycle can affect insulin sensitivity and blood sugar levels, potentially increasing variability.

Women are also more likely to report symptoms and seek care, which could explain some of the difference in reported rates. Regardless, if you're a woman on combination diabetes therapy, tracking your symptoms throughout your cycle may help you and your doctor identify patterns.

Recognizing Hypoglycemia: What to Watch For

Even if you're at low risk, knowing the signs of low blood sugar is essential:

Severe hypoglycemia can cause seizures or loss of consciousness and requires emergency treatment.

Reducing Your Risk: Practical Steps

If you fall into any higher-risk category, here's how to protect yourself:

Communicate with your doctor about all medications you're taking. When starting a GLP-1, your insulin or sulfonylurea doses may need to be reduced—sometimes by 20-50% or more.

Monitor your blood sugar more frequently when starting or adjusting doses, especially if you're on insulin or sulfonylureas.

Carry fast-acting glucose with you—glucose tablets, juice, or regular soda—if you're on combination therapy.

Eat consistently even if the GLP-1 reduces your appetite. Focus on balanced meals with protein, healthy fats, and complex carbohydrates.

Limit alcohol or always consume it with food if you choose to drink.

Wear medical identification if you're on insulin or have a history of severe hypoglycemia.

From the Ozari Care Team

If you're taking other diabetes medications alongside your GLP-1, proactive dose adjustments are key to preventing hypoglycemia. We typically recommend reducing sulfonylurea or insulin doses before starting GLP-1 therapy, then adjusting further based on your blood sugar patterns. Never stop or adjust diabetes medications on your own—work closely with your healthcare provider to make changes safely.

At Ozari Health we offer compounded Semaglutide and Tirzepatide as low as $99/month prescribed by licensed physicians and shipped to your door. Learn more at ozarihealth.com.

Medically Reviewed — Ozari Clinical Content Team (OCCT). Health writers and wellness professionals specializing in GLP-1 therapy, metabolic health, and weight loss medicine. Content reviewed in accordance with Ozari's Editorial Standards. Last reviewed: April 25, 2026.

This content is for informational purposes only and does not constitute medical advice. Always consult a licensed healthcare provider before starting any medication.

Last reviewed: April 25, 2026